ProNAi Therapeutics, Inc. DNAI was a big mover last session, as the company saw its shares rise over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company, as the stock is now down over 9% in the past one-month time frame.
The company has seen two positive revisions in the past one month, while its Zacks Consensus Estimate moved higher over the same time frame, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
Pronai Therapeutics currently carries a Zacks Rank #2 (Buy).
Another favorably ranked stock in the same industry is ANI PHARMACEUT ANIP, which sports a Zacks Rank #1 (Strong Buy).
Is DNAI going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment